| B | K | M | N | |
|---|---|---|---|---|
1 | Analysis Accession | Phenotype/WG | Accession Link | |
2 | pha003869.1 | Fatty acids | A GWA Meta-Analysis Of Alpha-Linoleic Acid (ALA) | |
3 | pha003870.1 | Fatty acids | A GWA Meta-Analysis Of Docosahexaenoic Acid (DHA) | |
4 | pha003871.1 | Fatty acids | A GWA Meta-Analysis Of Docosapentaenoic Acid (DPA) | |
5 | pha003872.1 | Fatty acids | A GWA Meta-Analysis Of Eicosapentaenoic Acid (EPA) | |
6 | pha003873.1 | Hematology | A GWA Meta-Analysis Of White Blood Cell Count (WBC) | |
7 | pha003874.1 | Hematology | A GWA Meta-Analysis Of Basophil Count | |
8 | pha003875.1 | Hematology | A GWA Meta-Analysis Of Eosinophil Count | |
9 | pha003876.1 | Hematology | A GWA Meta-Analysis Of Lymphocyte Count | |
10 | pha003877.1 | Hematology | A GWA Meta-Analysis Of Monocyte Count | |
11 | pha003878.1 | Hematology | A GWA Meta-Analysis Of Neutrophil Count | |
12 | pha003879.1 | Subclinical Atherosclerosis | A GWA Meta-Analysis Of Common Carotid Artery IMT | |
13 | pha003880.1 | Subclinical Atherosclerosis | A GWA Meta-Analysis Of Carotid Artery Plaque | |
14 | pha003886.1 | Cardiovascular Diseases | A GWA Meta-Analysis Of MI In Response To ACE Inhibitors | |
15 | pha003887.1 | Cardiovascular Diseases | A GWA Meta-Analysis Of MI In Response To Beta Blockers | |
16 | pha003888.1 | Cardiovascular Diseases | A GWA Meta-Analysis Of MI In Response To Calcium Channel Blockers | |
17 | pha003889.1 | Cardiovascular Diseases | A GWA Meta-Analysis Of MI In Response To Thiazide Diuretics | |
18 | pha003890.1 | Cardiovascular Diseases | A GWA Meta-Analysis Of CVD In Response To ACE Inhibitors | |
19 | pha003891.1 | Cardiovascular Diseases | A GWA Meta-Analysis Of CVD In Response To Beta Blockers | |
20 | pha003892.1 | Cardiovascular Diseases | A GWA Meta-Analysis Of CVD In Response To Calcium Channel Blockers | |
21 | pha003893.1 | Cardiovascular Diseases | A GWA Meta-Analysis Of CVD In Response To Thiazide Diuretics | |
22 | pha003895.1 | Pulmonary | A GWA Meta-Analysis Of FEV1 In Cohorts Of European Ancestry | |
23 | pha003896.1 | Pulmonary | A GWA Meta-Analysis Of FEV1 In Ever Smokers In Cohorts Of European Ancestry | |
24 | pha003897.1 | Pulmonary | A GWA Meta-Analysis Of FEV1 In Never Smokers In Cohorts Of European Ancestry | |
25 | pha003898.1 | Pulmonary | A GWA Meta-Analysis Of FEV1/FVC In Cohorts Of European Ancestry | |
26 | pha003899.1 | Pulmonary | A GWA Meta-Analysis Of FEV1/FVC In Ever Smokers In Cohorts Of European Ancestry | |
27 | pha003900.1 | Pulmonary | A GWA Meta-Analysis Of FEV1/FVC In Never Smokers In Cohorts Of European Ancestry | |
28 | pha003901.1 | Pulmonary | A GWA Meta-Analysis Of SNP And SNP-By-Smoking Interaction (Ever/Never) For FEV1 | |
29 | pha003902.1 | Pulmonary | A GWA Meta-Analysis Of SNP And SNP-By-Smoking Interaction (Pack-Years) For FEV1 | |
30 | pha003903.1 | Pulmonary | A GWA Meta-Analysis Of SNP And SNP-By-Smoking Interaction (Ever/Never) For FEV1/FVC | |
31 | pha003904.1 | Pulmonary | A GWA Meta-Analysis Of SNP And SNP-By-Smoking Interaction (Pack-Years) For FEV1/FVC | |
32 | pha003905.1 | Pulmonary | A GWA Meta-Analysis And Large Scale Followup Of FEV1 In Ever Smokers In Cohorts Of European Ancestry | |
33 | pha003906.1 | Pulmonary | A GWA Meta-Analysis And Large Scale Followup Of FVC In Ever Smokers In Cohorts Of European Ancestry | |
34 | pha003907.1 | Pulmonary | A GWA Meta-Analysis And Large Scale Followup Of FEV1/FVC In Ever Smokers In Cohorts Of European Ancestry | |
35 | pha003910.1 | Cardiovascular Diseases | A GWA Meta-Analysis For Incident Coronary Heart Disease | |
36 | pha003911.1 | Cardiovascular Diseases | A GWA Meta-Analysis For Incident Myocardial Infarction | |
37 | pha003912.1 | Inflammation | A Meta-Analysis For Fibrinogen Concentration | |
38 | pha003913.1 | Pulmonary | A GWA Meta-Analysis Of The Rate Of Change In Forced Expiratory Volume In The First Second (FEV1) In 14 Longitudinal Cohorts Of European Ancestry | |
39 | pha003914.1 | Pulmonary | A GWA Meta-Analysis Of Airway Obstruction In Cohorts Of European Ancestry-ALL | |
40 | pha003915.1 | Pulmonary | A GWA Meta-Analysis Of Airway Obstruction In Cohorts Of European Ancestry-SMOKER | |
41 | pha003916.1 | Pulmonary | A GWA Meta-Analysis Of Airway Obstruction In Cohorts Of European Ancestry-NONSMOKER | |
42 | pha003917.1 | Pulmonary | A GWA Meta-Analysis Of Airway Obstruction In Cohorts Of European Ancestry-NoAsthma | |
43 | pha003918.1 | Pulmonary | A GWA Meta-Analysis Of Airway Obstruction In Cohorts Of European Ancestry-FEV1_65 | |
44 | pha004249.1 | Blood pressure | An Exomechip Meta-Analysis In 10 Cohorts (19,896 African Ancestry Subjects) For Diastolic Blood Pressure | |
45 | pha004250.1 | Blood pressure | An Exomechip Meta-Analysis In 15 Cohorts (120,473 European Ancestry Subjects) For Diastolic Blood Pressure | |
46 | pha004251.1 | Blood pressure | An Exomechip Meta-Analysis In 2 Cohorts (4586 Hispanic Ancestry Subjects) For Diastolic Blood Pressure | |
47 | pha004252.1 | Blood pressure | An Exomechip Meta-Analysis In 16 Cohorts (146,562 Subjects) For Diastolic Blood Pressure | |
48 | pha004253.1 | Blood pressure | An Exomechip Meta-Analysis In 10 Cohorts (19,896 Subjects Of African Ancestry) For Systolic Blood Pressure | |
49 | pha004254.1 | Blood pressure | An Exomechip Meta-Analysis In 15 Cohorts (120,473 European Ancestry Subjects) For Systolic Blood Pressure | |
50 | pha004255.1 | Blood pressure | An Exomechip Meta-Analysis In 2 Cohorts (4586 Hispanic Ancestry Subjects) For Systolic Blood Pressure | |
51 | pha004256.1 | Blood pressure | An Exomechip Meta-Analysis In 16 Cohorts (146,562 Subjects) For Systolic Blood Pressure | |
52 | pha004257.1 | Blood pressure | An Exomechip Meta-Analysis In 10 Cohorts 19,896 African Ancestry Subjects) For Hypertension | |
53 | pha004258.1 | Blood pressure | An Exomechip Meta-Analysis In 15 Cohorts 120,473 European Ancestry Subjects) For Hypertension | |
54 | pha004259.1 | Blood pressure | An Exomechip Meta-Analysis In 2 Cohorts 4586 Hispanic Ancestry Subjects) For Hypertension | |
55 | pha004260.1 | Blood pressure | An Exomechip Meta-Analysis In 16 Cohorts (146,562 Subjects) For Hypertension | |
56 | pha004261.1 | Blood pressure | An Exomechip Meta-Analysis In 10 Cohorts (19,896 African Ancestry Subjects) For Mean Arterial Blood Pressure | |
57 | pha004262.1 | Blood pressure | An Exomechip Meta-Analysis In 15 Cohorts (120,473 European Ancestry Subjects) For Mean Arterial Blood Pressure | |
58 | pha004263.1 | Blood pressure | An Exomechip Meta-Analysis In 2 Cohorts (4586 Hispanic Ancestry Subjects) For Mean Arterial Blood Pressure | |
59 | pha004264.1 | Blood pressure | An Exomechip Meta-Analysis In 16 Cohorts (146,562 Subjects) For Mean Arterial Blood Pressure | |
60 | pha004265.1 | Blood pressure | An Exomechip Meta-Analysis In 10 Cohorts (19,896 Subjects Of African Ancestry) For Pulse Pressure | |
61 | pha004266.1 | Blood pressure | An Exomechip Meta-Analysis In 15 Cohorts (120,473 Subjects Of European Ancestry) For Pulse Pressure | |
62 | pha004267.1 | Blood pressure | An Exomechip Meta-Analysis In 2 Cohorts (4586 Subjects Of Hispanic Ancestry) For Pulse Pressure | |
63 | pha004268.1 | Blood pressure | An Exomechip Meta-Analysis In 16 Cohorts (146,562 Subjects) For Pulse Pressure | |
64 | pha004269.1 | Glucose/Insulin | A Meta-Analysis For Circulating IGF-1 Levels In Men | |
65 | pha004270.1 | Glucose/Insulin | A Meta-Analysis For Circulating IGF-1 Level In Women | |
66 | pha004271.1 | Glucose/Insulin | A Meta-Analysis For Circulating IGF-1 Level | |
67 | pha004272.1 | Glucose/Insulin | A Meta-Analysis For Circulating IGFBP-3 Level In Men | |
68 | pha004273.1 | Glucose/Insulin | A Meta-Analysis For Circulating IGFBP-3 Level In Women | |
69 | pha004274.1 | Glucose/Insulin | A Meta-Analysis For Circulating IGFBP-3 Level | |
70 | pha004275.1 | Hematology | A Meta-Analysis For PAI-1 Level In European Ancestry Populations | |
71 | pha004276.1 | Hematology | A Meta-Analysis For Circulating Tissue Plasminogen Activator (TPA) Levels | |
72 | pha004503.1 | EKG | A Meta-Analysis For SNP Modification Of The Association Between Tri/Tetracyclic Antidepressants And QT Interval In African-Ancestry Cohorts | |
73 | pha004504.1 | EKG | A Meta-Analysis For SNP Modification Of The Association Between Tri/Tetracyclic Antidepressants And QT Interval In European-Ancestry Caucasians | |
74 | pha004505.1 | EKG | A Meta-Analysis For SNP Modification Of The Association Between Tri/Tetracyclic Antidepressants And QT Interval In Hispanic/Latino Americans | |
75 | pha004506.1 | EKG | A Meta-Analysis For SNP Modification Of The Association Between Tri/Tetracyclic Antidepressants And RR Interval In African Americans | |
76 | pha004507.1 | EKG | A Meta-Analysis For SNP Modification Of The Association Between Tri/Tetracyclic Antidepressants And RR Interval In European-Ancestry Caucasians | |
77 | pha004508.1 | EKG | A Meta-Analysis For SNP Modification Of The Association Between Tri/Tetracyclic Antidepressants And RR Interval In Hispanic/Latino Americans | |
78 | pha004509.1 | Dementia/Cognitive | An Exomechip Single Variant Meta-Analysis Of Late-Onset Alzheimer Disease (LOAD) In European-Ancestry Caucasians | |
79 | pha004510.1 | Inflammation | An GWAS Meta-Analysis In 15 Cohorts (66,185 European Ancestry Subjects) For C-Reactive Protein (CRP) | |
80 | pha004511.1 | Dietary | A GWA Meta-Analysis Of Alcohol Drinking (As A Continuous Trait) In Men | |
81 | pha004512.1 | Dietary | A GWA Meta-Analysis Of Alcohol Drinking (As A Continuous Trait) In Women | |
82 | pha004513.1 | Dietary | A GWA Meta-Analysis Of Alcohol Drinking As A Continuous Trait | |
83 | pha004514.1 | Dietary | A GWA Meta-Analysis Of Alcohol Drinking As A Dichotomous Trait In Men | |
84 | pha004515.1 | Dietary | A GWA Meta-Analysis Of Alcohol Drinking As A Dichotomous Trait In Women | |
85 | pha004516.1 | Dietary | A GWA Meta-Analysis Of Alcohol Drinking As A Dichotomous Trait | |
86 | pha004517.1 | Dementia/Cognitive | An Exomechip Gene-Burden Meta-Analysis Of Late-Onset Alzheimer Disease (LOAD) In European-Ancestry Caucasians | |
87 | pha004518.1 | Hematology | A GWAS Trans-Ethnic Meta-Analysis Of Six Erythrocyte Traits | |
88 | pha004597.1 | EKG | A Meta-Analysis Of QRS Interval From The ECG Interacting With Sulfonylurea Use In African Ancestry Populations | |
89 | pha004598.1 | EKG | A Meta-Analysis Of QRS Interval From The ECG Interacting With Sulfonylurea Use In European Ancestry Populations | |
90 | pha004599.1 | EKG | A Meta-Analysis Of QRS Interval From The ECG Interacting With Sulfonylurea Use In Hispanic Ancestry Populations | |
91 | pha004600.1 | EKG | A Meta-Analysis Of QT Interval From The ECG Interacting With Sulfonylurea Use In African Ancestry Populations | |
92 | pha004601.1 | EKG | A Meta-Analysis Of QT Interval From The ECG Interacting With Sulfonylurea Use In European Ancestry Populations | |
93 | pha004602.1 | EKG | A Meta-Analysis Of QT Interval From The ECG Interacting With Sulfonylurea Use In Hispanic Ancestry Populations | |
94 | pha004603.1 | EKG | A Meta-Analysis Of JT Interval From The ECG Interacting With Sulfonylurea Use In African Ancestry Populations | |
95 | pha004604.1 | EKG | A Meta-Analysis Of JT Interval From The ECG Interacting With Sulfonylurea Use In European Ancestry Populations | |
96 | pha004605.1 | EKG | A Meta-Analysis Of JT Interval From The ECG Interacting With Sulfonylurea Use In Hispanic Ancestry Populations | |
97 | pha004606.1 | Lipids | A Meta-Analysis Of Low-Frequency And Rare Coding Variants With HDL In African Ancestry Populations | |
98 | pha004607.1 | Lipids | A Meta-Analysis Of Low-Frequency And Rare Coding Variants With HDL In European Ancestry Populations | |
99 | pha004608.1 | Lipids | A Meta-Analysis Of Low-Frequency And Rare Coding Variants With LDL In African Ancestry Populations | |
100 | pha004609.1 | Lipids | A Meta-Analysis Of Low-Frequency And Rare Coding Variants With LDL In European Ancestry Populations |